论文部分内容阅读
本文旨在研究需维持血液透析(血透)的终末期肾病(end-stage renal disease,ESRD)患者,血透对血浆儿茶酚胺的影响。作者观察11例患者(男5,女6),年龄30～85(平均56.5±20.4)岁。其中糖尿病肾病变5例,慢性肾炎3例,高血压肾硬化3例。观察期间均未服用降压药及可能影响血浆儿茶酚胺测定的药物。血透前平均血压为151±18/73±14mmHg。所有患者内生肌酐清除率(Ccr)为0～4ml/min。患者均取半卧位,30分钟
This article aims to investigate the effect of hemodialysis on plasma catecholamines in patients with end-stage renal disease (ESRD) requiring hemodialysis (hemodialysis). The authors observed 11 patients (5 males and 6 females) aged 30 to 85 years (mean 56.5 ± 20.4 years). Including diabetic nephropathy in 5 cases, 3 cases of chronic nephritis, hypertensive nephrosclerosis in 3 cases. During the observation period were not taking antihypertensive drugs and may affect the determination of plasma catecholamines drugs. The mean blood pressure before dialysis was 151 ± 18/73 ± 14 mmHg. All patients with endogenous creatinine clearance (Ccr) of 0 ~ 4ml / min. Patients take semi-recumbent position, 30 minutes